Table 2.
Inhibitory role of ginseng in inflammasome activation.
| Target | Ginseng | Components | Models | Ref. |
|---|---|---|---|---|
| NLRP3 | Panax ginseng | Rb1 | 3T3-L1, adipose tissue | [55] |
| Gouty arthritic rats | [56] | |||
| Rg1 | NAFLD mice | [57] | ||
| Liver injury mice | [58,59] | |||
| BNCC337685, diabetic nephropathy rats | [60] | |||
| Diabetic mice | [61] | |||
| Cardiomyocytes, myocardial injury mice | [62] | |||
| Rg2 | KC, NAFLD mice | [63] | ||
| Rg3 | RAW264.7, sepsis mice | [64] | ||
| BMDMs, THP-1, sepsis mice | [65] | |||
| HK-2, kidney injury mice | [66] | |||
| AC16, HCM, cardiomyocytes, myocardial hypertrophy rats | [67] | |||
| Rg5 | Diabetic nephropathy mice | [68] | ||
| Rd | THP-1, colitis mice | [69] | ||
| Cerebral IRI mice | [70] | |||
| Re | Memory impairment mice | [71] | ||
| Rh1 | BMDMs, THP-1, sepsis mice | [65] | ||
| KC, NAFLD mice | [63] | |||
| 25-OCH3-PPD | HSC-T6, hepatic fibrosis mice | [72] | ||
| CK | Atherosclerotic mice | [73] | ||
| 3T3-L1, adipose tissue | [55] | |||
| KRG extract | BMDMs, THP-1, sepsis mice | [65] | ||
| KRG saponins | Aging mice | [74] | ||
| Panax japonicus | CS IVa | BMDMs, adipocytes, obese mice | [75] | |
| Neurons, POCD rats | [76] | |||
| Panax quinquefolius | PF11 | Cognition impaired mice | [77] | |
| Panax notoginseng | Total saponins | Aging rats | [78] | |
| NLRP1 | Panax ginseng | Rg1 | Neuronal injury mice | [79] |
| Rg1 | Hippocampal neurons, neuronal injury mice | [80] | ||
| AIM2 | Panax ginseng | Rg3 | BMDMs, THP-1, sepsis mice | [65] |
| Fructose-arginine | BMDMs | [81] | ||
| Caspase-11 | Panax ginseng | KRG extract | J774A.1, sepsis mice | In press |
| Caspase-4 | Rh2 | Human lung cancer cells | [91] |